10-羟基喜树碱纳米微球的制备及表征

PDF(4340 KB)

北京化工大学学报（自然科学版） ›› 2014, Vol. 41 ›› Issue (5) : 83-88.

生物技术和环境工程

10-羟基喜树碱纳米微球的制备及表征

李瑞端;张建军;陈建峰*;滕巍

作者信息 +

Preparation and characterization of 10-hydroxycamptothecin nanoparticles

LI RuiDuan;ZHANG JianJun;CHEN JianFeng;TENG Wei

Author information +

文章历史 +

摘要

采用溶剂-反溶剂重结晶法进行了10-羟基喜树碱纳米化的研究。考察了以水为反溶剂，不同溶剂对10-羟基喜树碱纳米化的影响，以及不同溶剂反溶剂体积比和表面活性剂用量对其颗粒形貌和大小的影响。实验结果表明选择二甲基亚砜为溶剂，水为反溶剂的溶剂反溶剂效果最好，体系重结晶后形成的10-羟基喜树碱颗粒形貌为球形，粒径均一，约为95nm，添加聚乙烯吡咯烷酮增加了纳米化10-羟基喜树碱悬浮液的稳定性。XRD、FT-IR分析测试结果表明，纳米化颗粒为结晶型，结晶度比原料药低，但其化学结构和组分都与原料药相同；纳米化10-羟基喜树碱溶出速率远远大于原料药的溶出速率，在第30min时，纳米化10-羟基喜树碱的溶出累积量已近于100%，而原料药的溶出量仅为11.6%。

Abstract

10-Hydroxycamptothecin (HCPT) nanodispersions have been prepared by using an anti-solvent precipitation method．The influence of different solvents on the nanodispersion of 10-hydroxycamptothecin were investigated,with water as anti-solvent.DMSO was chosen as solvent to prepared nanosized 10-hydroxycamptothecin. The influence of the key parameters,including the volume ratio of solvent and anti-solvent and the weight of PVP,on the particle morphology,size and size distribution have been explored．The average particle size was about 95nm.The XRD spectra show that compared with the crude HCPT,the nano HCPT has lower crystallinity,and the FT-IR spectra show that the nano HCPT and crude HCPT have the same chemical structure and composition.The dissolution rate of nano 10-hydroxycamptothecin was significantly faster than that of the raw material.In the first 30min,the cumulative dissolved amount of the nano 10-hydroxycamptothecin was nearly 100%,while the dissolution of the raw material was only 11.6%.

引用本文

EndNote

Ris (Procite)

Bibtex

导出引用

李瑞端;张建军;陈建峰*;滕巍. 10-羟基喜树碱纳米微球的制备及表征[J]. 北京化工大学学报（自然科学版）, 2014, 41(5): 83-88

LI RuiDuan;ZHANG JianJun;CHEN JianFeng;TENG Wei. Preparation and characterization of 10-hydroxycamptothecin nanoparticles[J]. Journal of Beijing University of Chemical Technology, 2014, 41(5): 83-88

参考文献

[1] Bhattachar S N, Wesley J A, Fioritto A, et al. Dissolution testing of a poorly soluble compound using the flowthrough cell dissolution apparatus[J]. International Journal of Pharmaceutics, 2002, 236: 135-143.
[2] Posti J, Katila K, Kostiainen T. Dissolution rate limited bioavailability of flutamide, and in vitroin vivo correlation[J]. European Journal of Pharmaceutics and Biopharmaceutics, 2000, 49: 35-39.
[3] Shah V P, Noory A, Noory C, et al. In vitro dissolution of sparingly watersoluble drug dosage forms[J]. International Journal of Pharmaceutics, 1995, 125: 99-106. 
[4] Sakuma S, Sudo R, Suzuki N, et al. Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract[J]. International Journal of Pharmaceutics, 1999, 177: 161-172.
[5] Shively M L, Myers S. Solidstate emulsions: the effect of process and storage conditions[J]. Pharmaceutical Research, 1993, 10(7): 1071-1075.
[6] Ward G H, Schultz R K. Processinduced crystallinity changes in albuterol sulfate and its effect on powder physical stability[J]. Pharmaceutical Research, 1995, 12(5): 773-779.
[7] Betageri G V, Makarla K R. Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques[J]. International Journal of Pharmaceutics, 1995, 126: 155-160.
[8] Rasenack N, Müller B W. Dissolution rate enhancement by in situ micronization of poorly watersoluble drugs[J]. Pharmaceutical Research, 2002, 19(12): 1894-1900.
[9] Jiang Y B, Sun W L, Wang W. Recrystallization and micronization of 10hydroxycamptothecin by supercritical antisolvent process[J]. Industrial & Engineering Chemistry Research, 2012, 51(6): 2596-2602.
[10] Yang J, Cho E J, Seo S, et al. Enhancement of cellular binding efficiency and cytotoxicity using polyethylene glycol base triblock copolymeric nanoparticles for targeted drug delivery[J]. Journal of Biomedical Materials Research, 2008, 84A: 273-280.
[11] 中国药典[M]. 2版. 北京: 化学工业出版社， 2005: 309-310.
China Pharmacopoeia Commission[M]. 2nd ed. Beijing: Chemical Industry Press, 2005: 309-310. (in Chinese)
[12] 王莹, 祖元刚, 赵修华. 羟基喜树碱纳米颗粒超声反溶剂法制备工艺及表征[J]. 植物研究, 2012, 32(3): 369-372.
Wang Y, Zu Y G, Zhao X H. Preparation and characterization of hydroxycamptothecin nanoparticles using antisolvent ultrasonic method[J]. Bulletin of Botanical Research, 2012, 32(3): 369-372. (in Chinese)
[13] 黄微, 王平, 王蔚, 等. 甘草次酸修饰PEG-PLGA纳米粒的制备及与肝癌细胞的亲和性[J]. 高等学校化学学报, 2011, 32(2): 416-420.
Huang W, Wang P, Wang W, et al. Preparation of glycyrrhetinic acidmodified PEG-PLGA nanoparticles and the affinity evaluation on hepatoma cells[J]. Chemical Journal of Chinese Universities, 2011, 32(2): 416-420. (in Chinese)

PDF(4340 KB)

1743

Accesses

Citation

Detail

段落导航

摘要
Abstract
引用本文
参考文献

收稿日期	修回日期	出版日期
2014-03-10	1900-01-01	2014-09-20
发布日期
2014-09-20

选择文件类型/文献管理软件名称

选择包含的内容

摘要

Abstract

引用本文

{{custom_sec.title}}

{{custom_sec.title}}

参考文献

{{custom_fnGroup.title_cn}}

脚注

联系我们

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

摘要

Abstract

引用本文

{{custom_sec.title}}

{{custom_sec.title}}

参考文献

{{custom_fnGroup.title_cn}}

脚注

联系我们